We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry AMD Trial

News   Jun 24, 2014

 
StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry AMD Trial
 
 
 

RELATED ARTICLES

Stem Cell Transplant Variables That May Help Eradicate HIV

News

Study shows for the first time that stem cell source, time to achieve full replacement of recipient cells with donor cells, and graft-versus-host reactivity might contribute to HIV eradication.

READ MORE

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE